Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage and Associated Mood and Physiological Effects
PHASE1CompletedINTERVENTIONAL
Enrollment
75
Participants
Timeline
Start Date
October 8, 2021
Primary Completion Date
February 6, 2022
Study Completion Date
February 6, 2022
Conditions
Alertness
Interventions
OTHER
Flavored caffeinated beverage
16.9 oz (500 cc), carbonated, zero calorie
Trial Locations (1)
56529
AXIS Clinicals, Dilworth
All Listed Sponsors
lead
PepsiCo Global R&D
INDUSTRY
NCT05096780 - Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage and Associated Mood and Physiological Effects | Biotech Hunter | Biotech Hunter